Substance Use Disorders Among Psychiatric Inpatients: Prevalence, Pattern and Co-Morbidities

Journal Title: International Journal of Health & Medical Research - Year 2024, Vol 3, Issue 08

Abstract

Substance use disorders are disorders of global health concern as they are part of the NMDS group of disorders earmarked for attention by the World Health Organization through the mental health gap action programme (mhgap) and they contribute to the global burden of disease. The global annual prevalence of drug use among adult population of 15 – 64 years of age was reported as 5.6%, while in Nigeria, it was 14.4%. Apart from alcohol, cannabis was the most used substance, while cocaine was the least used in Nigeria.[1] In another report, the burden of substance use in Nigeria among students and youths was found to be about 20%.[2] Prevalence is the number or frequency of existing cases of disease in a defined population at a given point in time.[3] Substance use disorders refer to conditions arising from the misuse of alcohol, psychoactive drugs, or other chemicals such as volatile substances. These include intoxication, harmful use, dependence, amnestic disorder, substance-induced psychotic disorder etc.[4] In a cross-sectional study conducted among patients admitted to four public hospitals in South Africa, tobacco and alcohol were the most misused substances and the median age of respondents was 38 years.[5] In a similar study done on the determinants and prevalence of relapse among admitted patients with substance use disorders in Rwanda, Kabisa and colleagues found that majority of the respondents (84.1%) were males and that poly-substance use, living with peers and hospitalization of less than 3 months were associated with higher rates of relapse.[6] In a study among patients attending an emergency hospital in Egypt, cannabis was found to be the most abused drug, followed by tramadol. Predictors of substance abuse were: younger age (below 30 years), male and being single with unsatisfactory income

Authors and Affiliations

DR ADEKEYE, A. P. ,DR LAWAL, M. A. ,DR ELEGBEDE,A. O. ,DR AKANBI, S. A. ,DR ANNAFI, B. S. ,DR IGBINLADE,A. S. ,DR ABIDAKUN, O. O.

Keywords

Related Articles

Substance Use Disorders Among Psychiatric Inpatients: Prevalence, Pattern and Co-Morbidities

Substance use disorders are disorders of global health concern as they are part of the NMDS group of disorders earmarked for attention by the World Health Organization through the mental health gap action programme (mhg...

An In-Depth Case Study of A 28 Years Old Patient Having PCOD with Hair Loss and Acne Healed Successfully Using Yoga Prana Vidya (YPV) Healing Protocols

Introduction: PCOD (Polycystic Ovarian Disease) is a very disturbing condition of women of reproductive age, a common endocrine and metabolic disorder. Management of PCOD is a complex process, with inevitable long-term...

Improving Nurses’ Proficiency In Providing Nursing Care For Pediatric Tonsillectomy

Objective: Tonsillectomy is the most common surgery in the field of ENT. Pain is the most common post tonsillectomy complaint. Considering the importance of nursing cares in relieving post-surgery pain in general and pos...

Gestational Syphilis in Santos/Sp: Epidemiologic Analysis From 2016 To 2022

Introduction: This study analyzes the incidence and trends of gestational syphilis in the city of Santos/SP between 2016 and 2022. Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum,...

Molecular Docking Approach Reveals the Potential Role of Psidium Guajava Leaf Extract Compounds as Quorum-Sensing Inhibitors Targeting Pseudomonas Aeruginosa’s Lasr

Quorum-sensing LasR antagonism is evolving as a primary focus in promising new antivirulence approaches for treating bacterial infections. Pseudomonas aeruginosa’s LasR is a target receptor for developing alternative me...

Download PDF file
  • EP ID EP750588
  • DOI 10.58806/ijhmr.2024.v3i08n18
  • Views 2
  • Downloads 0

How To Cite

DR ADEKEYE, A. P. , DR LAWAL, M. A. , DR ELEGBEDE, A. O. , DR AKANBI, S. A. , DR ANNAFI, B. S. , DR IGBINLADE, A. S. , DR ABIDAKUN, O. O. (2024). Substance Use Disorders Among Psychiatric Inpatients: Prevalence, Pattern and Co-Morbidities. International Journal of Health & Medical Research, 3(08), -. https://europub.co.uk/articles/-A-750588